Publication | Closed Access

Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis : Routes of immunization and TLR agonists critically impact vaccine’s efficacy

VaccinationInflammationNovel LipopeptidesPulmonary TuberculosisMycobacterium TuberculosisImmunologyInnate Immune SystemTuberculosisImmune SystemCd4 T Cell ResponsesInnate ImmunityImmunotherapyMedicineVaccine Research